NCT06891040View on ClinicalTrials.gov

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

VC005 Placebo group

VC005 Placebo group with Local topical application

DRUG

VC005 groups

VC005 group with Local topical application

Trial Locations (1)

Unknown

RECRUITING

Chinese Academy of Medical Sciences Hospital of Skin Disease, Nanjing

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY